Phase Ia/Ib Trial of Anti-GD2 Chimeric Monoclonal Antibody 14.18 (ch l4.18) and Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhGM-CSF) in Metastatic Melanoma.

Autor:	Murray, James L., Kleinerman, Eugenie S., Jia, Shu-Fang, Rosenblum, Michael G., Eton, Omar, Buzaid, Antonio, Legha, Sewa, Ross, Merrick I., Thompson, Lora, Mujoo, Kalpana, Rieger, Paula T., Saleh, Mansoor, Khazaeli, M B, Vadhan-Raj, Saroj
Zdroj:	Journal of Immunotherapy; May1996, Vol. 19 Issue 3, p206-217, 12p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu